BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $685,952 | +3.6% | 21,483 | -0.7% | 0.00% | 0.0% |
| Q1 2023 | $662,433 | -15.1% | 21,634 | +8.4% | 0.00% | 0.0% |
| Q4 2022 | $780,518 | -22.7% | 19,957 | -5.8% | 0.00% | 0.0% |
| Q3 2022 | $1,010,000 | +21.0% | 21,193 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $835,000 | -97.8% | 21,577 | -96.9% | 0.00% | -97.4% |
| Q1 2022 | $38,776,000 | -15.8% | 685,186 | +18.6% | 0.04% | -7.1% |
| Q4 2021 | $46,035,000 | -24.2% | 577,670 | -17.2% | 0.04% | -28.8% |
| Q3 2021 | $60,723,000 | -11.7% | 697,879 | +30.7% | 0.06% | -10.6% |
| Q2 2021 | $68,747,000 | +44.7% | 534,129 | -10.0% | 0.07% | +34.7% |
| Q1 2021 | $47,513,000 | +648.8% | 593,605 | +663.8% | 0.05% | +600.0% |
| Q4 2020 | $6,345,000 | +158.3% | 77,719 | -22.1% | 0.01% | +133.3% |
| Q3 2020 | $2,456,000 | -25.8% | 99,741 | -15.6% | 0.00% | -25.0% |
| Q2 2020 | $3,309,000 | -65.3% | 118,178 | -77.7% | 0.00% | -50.0% |
| Q1 2020 | $9,536,000 | – | 529,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |